纳米银治疗感染性角膜炎的作用机制研究进展
Research Advances on the Mechanism of AgNPs in the Treatment of Infectious Keratitis
DOI: 10.12677/ACM.2022.12121665, PDF,   
作者: 张欣慧, 王宝蕙:济宁医学院,山东 济宁
关键词: 纳米银感染性角膜炎Silver Nanoparticles Infectious Keratitis
摘要: 感染性角膜炎是我国致盲眼病的重要原因,针对难治性的感染性角膜炎,传统的抗菌药物难以达到良好的治疗效果,纳米银具有较大的比表面积、较强的渗透力、耐氧化性和无耐药性,具有良好的抗微生物效果。本文就当前纳米抗微生物治疗感染性角膜炎的作用机制、应用前景进行综述。
Abstract: Infectious keratitis is an important cause of blindness in China. For refractory infectious keratitis, traditional antibacterial drugs are difficult to achieve good therapeutic effects, and nanosilver has a large specific surface area, strong permeability, oxidation resistance and no drug resistance, and has good anti-microbial effects. This article reviews the current mechanism of action and prospects for the application of nano-antimicrobial therapy for infectious keratitis.
文章引用:张欣慧, 王宝蕙. 纳米银治疗感染性角膜炎的作用机制研究进展[J]. 临床医学进展, 2022, 12(12): 11549-11554. https://doi.org/10.12677/ACM.2022.12121665

参考文献

[1] 张文华. 应重视感染性角膜病的综合治疗[J]. 中华眼科杂志, 1998, 34(1): 5-7.
[2] Aymonier, C., Schlotterbeck, U., Antonietti, L., et al. (2002) Hybrids of Silver Nanoparticles with Amphiphilic Hyperbranched Macromolecules Ex-hibiting Antimicrobial Properties. Chemical Communications, No. 24, 3018-3019. [Google Scholar] [CrossRef] [PubMed]
[3] 刘佳敏, 曹凯, 张子俊, 等. 近40年我国细菌性角膜炎病原学及药物敏感性变化Meta分析[J]. 中华实验眼科杂志, 2022, 40(2): 157-164.
[4] Bapat, R.A., Chaubal, T.V., Joshi, C.P., et al. (2018) An Overview of Application of Silver Nanoparticles for Biomaterials in Dentistry. Materials Science & Engi-neering C—Materials for Biological Applications, 91, 881-898. [Google Scholar] [CrossRef] [PubMed]
[5] Khorrami, S., Zarrabi, A., Khaleghi, M., et al. (2018) Selective Cytotoxicity of Green Synthesized Silver Nanoparticles against the MCF-7 Tumor Cell Line and Their Enhanced Anti-oxidant and Antimicrobial Properties. International Journal of Nanomedicine, 13, 8013-8024. [Google Scholar] [CrossRef
[6] Bondarenko, O.M., Sihtmäe, M., Kuzmičiova, J., et al. (2018) Plasma Membrane Is the Target of Rapid Antibacterial Action of Silver Nanoparticles in Escherichia coli and Pseudomonas ae-ruginosa. International Journal of Nanomedicine, 13, 6779-6790. [Google Scholar] [CrossRef
[7] Ramkumar, V.S., Pugazhendhi, A., Gopalakrishnan, K., et al. (2017) Biofabrication and Characterization of Silver Nanoparticles Using Aqueous Extract of Seaweed Enteromorpha com-pressa and Its Biomedical Properties. Biotechnology Reports (Amst), 14, 1-7. [Google Scholar] [CrossRef] [PubMed]
[8] Liao, C., Li, Y. and Tjong, S.C. (2019) Bactericidal and Cytotoxic Properties of Silver Nanoparticles. International Journal of Molecular Sciences, 20, 449. [Google Scholar] [CrossRef] [PubMed]
[9] Durán, N., Nakazato, G. and Seabra, A.B. (2016) Antimicrobial Activ-ity of Biogenic Silver Nanoparticles, and Silver Chloride Nanoparticles: An Overview and Comments. Applied Microbi-ology and Biotechnology, 100, 6555-6570. [Google Scholar] [CrossRef] [PubMed]
[10] Manna, D.K., Mandal, A.K., Sen, I.K., et al. (2015) Antibacterial and DNA Degradation Potential of Silver Nanoparticles Synthesized via Green Route. International Journal of Biological Macromolecules, 80, 455-459. [Google Scholar] [CrossRef] [PubMed]
[11] Dakal, T.C., Kumar, A., Majumdar, R.S., et al. (2016) Mecha-nistic Basis of Antimicrobial Actions of Silver Nanoparticles. Frontiers in Microbiology, 7, Article No. 1831. [Google Scholar] [CrossRef] [PubMed]
[12] Nguyen, D.D., Luo, L.J. and Lai, J.Y. (2021) Toward Understand-ing the Purely Geometric Effects of Silver Nanoparticles on Potential Application as Ocular Therapeutics via Treatment of Bacterial Keratitis. Materials Science & Engineering C—Materials for Biological Applications, 119, Article ID: 111497. [Google Scholar] [CrossRef] [PubMed]
[13] Salleh, A., Naomi, R., Utami, N.D., et al. (2020) The Potential of Silver Nanoparticles for Antiviral and Antibacterial Applications: A Mechanism of Action. Nanomaterials (Basel), 10, 1566. [Google Scholar] [CrossRef] [PubMed]
[14] Yin, I.X., Zhang, J., Zhao, I.S., et al. (2020) The Antibacterial Mechanism of Silver Nanoparticles and Its Application in Dentistry. International Journal of Nanomedicine, 15, 2555-2562. [Google Scholar] [CrossRef
[15] Zavarshani, M., Ahmadi, M., Dastmalchi, S.H., et al. (2019) Comparison Therapeutic Effects of Ciprofloxacin, Silver Nanoparticles and Their Combination in the Treatment of Pseu-domonas keratitis in Rabbit: An Experimental Study. Iranian Journal of Pharmaceutical Research, 18, 320-327.
[16] 中华医学会眼科学分会角膜病学组. 感染性角膜病临床诊疗专家共识(2011年) [J]. 中华眼科杂志, 2012, 48(1): 72-75.
[17] Prakash, G., Sharma, N., Goel, M., et al. (2008) Evaluation of Intrastromal Injection of Voriconazole as a Therapeutic Adjunctive for the Management of Deep Recalcitrant Fungal Keratitis. American Journal of Ophthalmology, 146, 56-59. [Google Scholar] [CrossRef] [PubMed]
[18] 刘涛, 丘亮辉. 结膜瓣遮盖术治疗难治性角膜溃疡的临床疗效[J]. 中国实用医刊, 2014, 41(10): 28-29.
[19] Jalal, M., Ansari, M.A., Alzohairy, M.A., et al. (2019) An-ticandidal Activity of Biosynthesized Silver Nanoparticles: Effect on Growth, Cell Morphology, and Key Virulence At-tributes of Candida Species. International Journal of Nanomedicine, 14, 4667-4679. [Google Scholar] [CrossRef
[20] Halbandge, S.D., Jadhav, A.K., Jangid, P.M., et al. (2019) Molecular Targets of Biofabricated Silver Nanoparticles in Candida albicans. The Journal of Antibiotics (Tokyo), 72, 640-644. [Google Scholar] [CrossRef] [PubMed]
[21] Gutiérrez, J.A., Caballero, S., Díaz, L.A., et al. (2018) High An-tifungal Activity against Candida Species of Monometallic and Bimetallic Nanoparticles Synthesized in Nanoreactors. ACS Biomaterials Science & Engineering, 4, 647-653. [Google Scholar] [CrossRef] [PubMed]
[22] Kim, K.J., Sung, W.S., Suh, B.K., et al. (2009) Antifungal Activity and Mode of Action of Silver Nano-Particles on Candida albicans. Biometals, 22, 235-242. [Google Scholar] [CrossRef] [PubMed]
[23] Hwang, I.S., Lee, J., Hwang, J.H., et al. (2012) Silver Nanoparti-cles Induce Apoptotic Cell Death in Candida albicans through the Increase of Hydroxyl Radicals. FEBS Journal, 279, 1327-1338. [Google Scholar] [CrossRef] [PubMed]
[24] 冯敏, 高杨, 杨亚丽, 等. 人类单纯疱疹病毒流行情况分析[J]. 中华微生物学和免疫学杂志, 2019(12): 937-950.
[25] Looker, K.J., Elmes, J., Gottlieb, S.L., et al. (2017) Effect of HSV-2 Infection on Subsequent HIV Acquisition: An Updated Systematic Review and Meta-Analysis. The Lancet Infectious Diseases, 17, 1303-1316. [Google Scholar] [CrossRef
[26] Orłowski, P., Kowalczyk, A., Tomaszewska, E., et al. (2018) Antiviral Activity of Tannic Acid Modified Silver Nanoparticles: Potential to Activate Immune Response in Herpes Gen-italis. Viruses, 10, 524. [Google Scholar] [CrossRef] [PubMed]
[27] Siddiqui, R., Dudley, R. and Khan, N.A. (2012) Acanthamoeba Differenti-ation: A Two-Faced Drama of Dr Jekyll and Mr Hyde. Parasitology, 139, 826-834. [Google Scholar] [CrossRef
[28] Diehl, M., Paes, J. and Rott, M.B. (2021) Genotype Distribution of Acanthamoeba in Keratitis: A Systematic Review. Parasitology Research, 120, 3051-3063. [Google Scholar] [CrossRef] [PubMed]
[29] Lorenzo-Morales, J., Khan, N.A. and Walochnik, J. (2015) An Update on Acanthamoeba keratitis: Diagnosis, Pathogenesis and Treatment. Parasite, 22, 10. [Google Scholar] [CrossRef] [PubMed]
[30] Anwar, A., Soomaroo, A., Anwar, A., et al. (2020) Metfor-min-Coated Silver Nanoparticles Exhibit Anti-Acanthamoebic Activities against both Trophozoite and Cyst Stages. Experimental Parasitology, 215, Article ID: 107915. [Google Scholar] [CrossRef] [PubMed]
[31] Padzik, M., Hendiger, E.B., Chomicz, L., et al. (2018) Tannic Acid-Modified Silver Nanoparticles as a Novel Therapeutic Agent against Acanthamoeba. Parasitology Research, 117, 3519-3525. [Google Scholar] [CrossRef] [PubMed]
[32] Anwar, A., Siddiqui, R., Hussain, M.A., et al. (2018) Silver Na-noparticle Conjugation Affects Anti-Acanthamoebic Activities of Amphotericin B, Nystatin, and Fluconazole. Parasitol-ogy Research, 117, 265-271. [Google Scholar] [CrossRef] [PubMed]
[33] Santoro, C.M., Duchsherer, N.L. and Grainger, D.W. (2007) An-timicrobial Efficacy and Ocular Cell Toxicity from Silver Nanoparticles. Nanobiotechnology, 3, 55-65. [Google Scholar] [CrossRef] [PubMed]
[34] Lee, H. and Park, K. (2019) In Vitro Cytotoxicity of Zinc Oxide Nanoparticles in Cultured Statens Seruminstitut Rabbit Cornea Cells. Toxicological Research, 35, 287-294. [Google Scholar] [CrossRef
[35] Luo, L.J., Lin, T.Y., Yao, C.H., et al. (2019) Dual-Functional Gela-tin-Capped Silver Nanoparticles for Antibacterial and Antiangiogenic Treatment of Bacterial Keratitis. Journal of Colloid and Interface Science, 536, 112-126. [Google Scholar] [CrossRef] [PubMed]
[36] Pecoraro, R., Salvaggio, A., Scalisi, E.M., et al. (2019) Evaluation of the Effects of Silver Nanoparticles on Danio Rerio Cornea: Morphological and Ultrastructural Analysis. Microscopy Research and Technique, 82, 1297-1301. [Google Scholar] [CrossRef] [PubMed]
[37] Barbasz, A., Oćwieja, M., Piergies, N., et al. (2021) Antioxi-dant-Modulated Cytotoxicity of Silver Nanoparticles. Journal of Applied Toxicology, 41, 1863-1878. [Google Scholar] [CrossRef] [PubMed]
[38] Hayasaka, T., Goto-Inoue, N., Zaima, N., et al. (2010) Imaging Mass Spec-trometry with Silver Nanoparticles Reveals the Distribution of Fatty Acids in Mouse Retinal Sections. Journal of the American Society for Mass Spectrometry, 21, 1446-1454. [Google Scholar] [CrossRef] [PubMed]